“Our ultimate goal is to be able to regenerate cardiomyocytes after an injury like a heart attack,” Dr. Reza Ardehali said. “But we’re first trying to learn from the embryonic heart.”
The five-year project funded by the National Institute of Allergy and Infectious Diseases will involve three projects to investigate factors that accelerate and prevent the re-emergence of HIV.
Chimeric antigen receptor T cell therapy fights disease by bolstering the body’s own natural defenses. Josh Feldman, diagnosed with lymphoma after returning from his honeymoon, knows the difference it can make.
“If the results ... are replicated in future studies, the methods we used could potentially give clinicians a new predictive tool,” said UCLA doctoral student Nicco Reggente.
Their technique would enable an average biochemistry laboratory to make its own sequences for only about $2 per gene, far less than the $50 to $100 per gene commercial vendors charge.
A UCLA-led analysis identifies brain measures of major psychiatric disease. Researchers also pinpointed important differences in these disorders’ gene expression.
The hardy marine invertebrates survive a bleaching process but their growth is slowed, a UCLA study conducted off the coast of American Samoa has found.
Study by the Williams Institute at UCLA School of Law contains first estimates of youth at risk of undergoing the practice health organizations say is harmful.
In places where UCLA researchers found higher levels of stigma, students were more likely to report they seek treatment from a religious group or a religious leader.
The substance’s beneficial properties might be due to its ability to reduce inflammation, which has been linked to both Alzheimer’s disease and major depression, according to Dr. Gary Small.
There is no drug or vaccine to treat or prevent KSHV, which causes cancer, but the researchers showed that an inhibitor could be developed to break it down.
UCLA scientists used leading-edge genomics to identify and eliminate the virus’ defense mechanisms, enabling them to develop a vaccine “candidate” that is safe and effective in animals.